diabetes mellitus. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: The first group will be consume two 500 mg powdered cinnamon capsules per day along with their meals for a period of three months. Intervention 2: The second group will be consume four
Treatment - Other
Placebo
The first group will be consume two 500 mg powdered cinnamon capsules per day along with their meals for a period of three months.
The second group will be consume four 500 mg powdered cinnamon capsules per day along with their meals for a period of three months.
The third group will be consume two 500 mg wheat flour capsules per day along with their meals for a period of three months.
Sponsors
Urmia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
63 Years to 33 Years
Inclusion criteria
Inclusion criteria: Criteria for inclusion in the study: Suffering from diabetes type 2? Diabetes record for more than two years ? Aged between 30 to 60 ? Consumption of glibenclamide, metformin, or undergoing diet therapy? Criteria for exclusion from the study:Suffering from diabetes type 1? Insulin Therapy? Suffering from liver diseases? Suffering from renal diseases? Suffering from thyroid diseases? Allergy to cinnamon? Pregnancy and lactation? Smoking and drinking alcohol?Consumption of drugs reducing blood fat and pressure? Change of type and dosage of consuming drugs during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: Before Intervention and three months after Intervention. Method of measurement: enzymatic method, mg/dl.;Insulin Resistance. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Fasting Blood Sugar(mg/dl)×Serum Insulin(µu/ml)÷405.;Serum Insulin. Timepoint: Before Intervention and three months after Intervention. Method of measurement: radioimmunoassay, µU/ml.;Age. Timepoint: before intervention. Method of measurement: questionnaire, year.;Hemoglobin A1C. Timepoint: Before Intervention and three months after Intervention. Method of measurement: HPLC method, percentage.;HDL cholesterol. Timepoint: Before Intervention and three months after Intervention. Method of measurement: enzymatic method, mg/dl.;Triglyceride. Timepoint: Before Intervention and three months after Intervention. Method of measurement: enzymatic method, mg/dl.;Total cholesterol. Timepoint: Before Intervention and three months after Intervention. Method of measurement: enzymatic method, mg/dl.;LDL cholesterol. Timepoint: Before Intervention and three months after Intervention. Method of measurement: enzymatic method, mg/dl.;Sex. Timepoint: before intevention. Method of measurement: questionnaire, male or female.;Systolic blood pressure. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mercury sphygmomanometer, mmHg.;Diastolic blood pressure. Timepoint: Before Intervention and three months after Intervention. Method of measurement: Mercury sphygmomanometer, mmHg.;Fat mass. Timepoint: Before Intervention and three months after Intervention. Method of measurement: BIA, percentage.;Fat free mass. Timepoint: Before Intervention and three months after Intervention. Method of measurement: BIA, percentage.;Total energy. Timepoint: Before Intervention and three months after Intervention. Method of measurement: food record questionnaire, Kcal.;Carbohydrate intake. Timepoint: Before Intervention and th | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed